Close

FBR Capital Starts Acceleron Pharma (XLRN) at Outperform

August 13, 2014 5:37 PM EDT Send to a Friend
FBR Capital initiates coverage on Acceleron Pharma (NASDAQ: XLRN) with a Outperform rating and a price target of $47.00.Analyst Andrew ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login